|
|
Article: MILLENNIUM/HARVARD MEDICAL SCHOOL SIGN CANCER RESEARCH PACT.
- Article from:
- Biotech Business
- Article date:
- March 1, 2008
|
Copyright informationCOPYRIGHT 2008 Worldwide Videotex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) and Harvard Medical School's Office of Technology Development have announced an innovative collaboration agreement to pursue a research program in the area of protein homeostasis, an emerging and expanding field of cancer biology. Under the terms of the agreement, Harvard has granted Millennium a "Harvard Medical School's research initiatives in protein homeostasis, license to certain invention from the laboratory of Professor J. Wade Harper and the two institutions will jointly advance the program in this novel area of research over several years under a sponsored research agreement. Financial terms were not disclosed.
...
Related newspaper, magazine, and journal articles:
|